Breakout Stocks of Week 16 @ TASE

NASDAQ was up by impressive 6.84% last week (week 15) ending at 24,468.48 points points after ending the week prior at 22,902.89 points. Normally this would indicate a weaker week ahead of us. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Kamada Ltd TASE:KMDA. This stock has had a buy signal since Apr 17, 2026 when the price was ₪2,502.00 , but have so far fallen 0% to ₪2,502.00. Some other companies are on our watchlist to, among these are Danya Cebus Ltd. TASE:DNYA F.i.b.i. Holdings Ltd TASE:FIBIH Meshek Energy - Renewable Energies Ltd. TASE:MSKE and Nextvison Stabilized Systems, Ltd. TASE:NXSN which all got a breakout pattern emerging.

Date Company Price Week 16
Apr 17, 2026 Kamada Ltd ₪2,502.00 ₪2,444.00 -2.32%
Apr 17, 2026 Danya Cebus Ltd. ₪16,700.00 ₪16,140.00 -3.35%
Apr 17, 2026 F.i.b.i. Holdings Ltd ₪31,080.00 ₪30,330.00 -2.41%
Apr 17, 2026 Meshek Energy - Renewable Energies Ltd. ₪1,116.00 ₪1,193.00 6.90%
Apr 17, 2026 Nextvison Stabilized Systems, Ltd. ₪29,090.00 ₪31,140.00 7.05%

Kamada Ltd

TASE:KMDA Hold/Accumulate Score: 0.103
Hold/Accumulate Score: 0.103 Apr 17, 2026

Kamada LtdThe Kamada Ltd stock price gained 0.281% on the last trading day (Friday, 17th Apr 2026), rising from ₪2,495.00 to ₪2,502.00. During the last trading day the stock fluctuated 3.10% from a day low at ₪2,451.00 to a day high of ₪2,527.00. The price has fallen in 7 of the last 10 days and is down by -3.81% for this period. Volume fell on the last day by -27 thousand shares and in total, 30 thousand shares were bought and sold for approximately ₪74.93 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Kamada Ltd holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

About Kamada Ltd:
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN for Allergic rhinitis and Urticaria; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for cytomegalovirus virus; RUCONEST for angioedema attacks; heparin sodium injection for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. Further, it offers IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis ; and ELIGARD for prostate cancer. The company markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceuticals Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.

Danya Cebus Ltd.

TASE:DNYA Hold/Accumulate Score: -0.495
Hold/Accumulate Score: -0.495 Apr 17, 2026

The Danya Cebus Ltd. stock price gained 4.70% on the last trading day (Friday, 17th Apr 2026), rising from ₪15,950.00 to ₪16,700.00. During the last trading day the stock fluctuated 6.10% from a day low at ₪15,910.00 to a day high of ₪16,880.00. The price has risen in 6 of the last 10 days and is up by 3.09% over the past 2 weeks. Volume fell on the last day by -4 thousand shares and in total, 25 thousand shares were bought and sold for approximately ₪413.74 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Danya Cebus Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

F.i.b.i. Holdings Ltd

TASE:FIBIH Hold/Accumulate Score: -0.95
Hold/Accumulate Score: -0.95 Apr 17, 2026

The F.i.b.i. Holdings Ltd stock price gained 2.27% on the last trading day (Friday, 17th Apr 2026), rising from ₪30,390.00 to ₪31,080.00. During the last trading day the stock fluctuated 3.44% from a day low at ₪30,230.00 to a day high of ₪31,270.00. The price has risen in 6 of the last 10 days and is up by 3.02% over the past 2 weeks. Volume fell on the last day by -3 thousand shares and in total, 29 thousand shares were bought and sold for approximately ₪894.73 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

F.i.b.i. Holdings Ltd holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Meshek Energy - Renewable Energies Ltd.

TASE:MSKE Sell Candidate Score: -1.35
Sell Candidate Score: -1.35 Apr 17, 2026

The Meshek Energy - Renewable Energies Ltd. stock price gained 1.45% on the last trading day (Friday, 17th Apr 2026), rising from ₪1,100.00 to ₪1,116.00. During the last trading day the stock fluctuated 4.14% from a day low at ₪1,086.00 to a day high of ₪1,131.00. The price has risen in 6 of the last 10 days and is up by 2.29% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 79 thousand more shares were traded than the day before. In total, 758 thousand shares were bought and sold for approximately ₪845.74 million.

Meshek Energy - Renewable Energies Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Nextvison Stabilized Systems, Ltd.

TASE:NXSN Sell Candidate Score: -1.48
Sell Candidate Score: -1.48 Apr 17, 2026

The Nextvison Stabilized Systems, Ltd. stock price gained 0.90% on the last trading day (Friday, 17th Apr 2026), rising from ₪28,830.00 to ₪29,090.00. During the last trading day the stock fluctuated 3.76% from a day low at ₪28,200.00 to a day high of ₪29,260.00. The price has fallen in 6 of the last 10 days and is down by -4.62% for this period. Volume fell on the last day by -258 thousand shares and in total, 156 thousand shares were bought and sold for approximately ₪4.52 billion. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The Nextvison Stabilized Systems, Ltd. stock holds several negative signals and despite the positive trend, we believe Nextvison Stabilized Systems, Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30
.

StockInvest.usStock Podcast